Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:56 AM
Ignite Modification Date:
2025-12-26 @ 10:56 AM
NCT ID:
NCT03785808
Eligibility Criteria:
Inclusion Criteria:
* Adults (18 years or older) receiving treatment at the Seattle Cancer Care Alliance (SCCA)
* Stage IIIB and IV non-small cell adenocarcinoma or squamous cell carcinoma, or small cell lung cancer with advanced disease receiving therapy with systemic treatment
* Body mass index (BMI) \>= 20 kg/m\^2
* Body weight within 10% of current weight within the 3 months before starting the study
* Able and willing to attend bi-weekly dietary support sessions at the Seattle Cancer Care Alliance (SCCA) during the initial 12-week intervention period
* Willing and able to follow the dietary regimen
* Willing to maintain usual lifestyle habits (other than diet) throughout the study (e.g., physical activity habits)
* Ability to understand, speak, and write in English
* Ability to provide informed written consent
Exclusion Criteria:
* Neuroendocrine large cell carcinoma or atypical carcinoids with metastatic disease
* Small cell lung cancer receiving curative therapy with radiation
* Use of antidiabetic medications or insulin within the last 6 months
* Presence of grade 2 weight loss, cachexia, and/or severe nausea
* Current participation in therapeutic first line trial
* Alcohol intake \> 2 drinks per day
* Major dietary restriction, as determined by the researcher
* Other significant health condition as determined by the researcher
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03785808
Study Brief:
Protocol Section:
NCT03785808